MedicalNewsToday New research suggests that in the United States, around 35% of excess deaths during the early phase of the pandemic were not directly caused by COVID-19. A new study has found that in the U.S., up to 35% of excess deaths during the early phase of the pandemic may not have been directly due […]
Read MoreDG Alerts Low mortality rate observed in a small case series published in Critical Care suggests that combination treatment of favipiravir and nafamostat mesylate may be effective for critically ill coronavirus disease 2019 (COVID-19) patients. “Nafamostat mesylate therapy in combination with favipiravir may allow blockade of virus entry and replication, as well as inhibition of pathogenic host […]
Read MoreAUTHORS: Hanidziar, Dusan MD, PhD et al Anesthesia & Analgesia: July 2020 – Volume 131 – Issue 1 – p e40-e41 To the Editor Management of patient sedation and analgesia to alleviate anxiety and pain and facilitate mechanical ventilation is one of the key roles of every intensivist. During the coronavirus disease 2019 (COVID-19) pandemic, […]
Read MoreAuthor: Michael Walter Cardiovascular Business A new study suggests COVID-19 has the potential to infect cardiac cells, causing changes in their ability to function after just 72 hours. The researchers found that SARS-CoV-2, the virus behind COVID-19, was capable of infecting heart muscle cells created with stem cell technology and stored in a lab dish. They […]
Read MoreAuthor: Michael Walter Cardiovascular Business News Work-related stress is associated with an increased risk of peripheral artery disease (PAD), according to a new study published in the Journal of the American Heart Association. Such stress is already considered a risk factor for a variety of atherosclerotic diseases. More than 200 million people around the world suffer from […]
Read More